Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single and repeated oral BCT197 in acute COPD exacerbations
2010-021723-27Phase 2Completed
- Sponsor
- Novartis
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing BCT197 with Placebo (2 arms). Primary endpoints: Improvement in FEV1 over first 5 days and Improvement in FEV1 over first 10 days (Parts III and IV). Started Feb 2011; status: completed.
02
Drugs
acumapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2010-021723-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021723-27.